- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00177606
Donors After Cardiac Death: Validating Identification Criteria
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Our study is a simple, observational study. We intend to record the events that occur between the time withdrawal of life sustaining treatment occurs, and the time of death. Our preliminary data, reported in the journals Critical Care Medicine and Pediatric Critical Care Medicine, show that the median time to death is about 25 minutes, and few survive over an hour. We would directly observe no patient for longer than one hour.
This is a straightforward study to characterize the Receiver Operator Characteristic (ROC) curves and Relative Risk of a variety of clinical data elements for predicting early death following discontinuation of life sustaining treatments. This is a multi-center study currently being conducted at: University of Cincinnati Hospital, Case-Western Reserve University Hospital and the University of Pittsburgh Medical Center with the University of Pittsburgh acting as the Coordinating Center. (a) This is a prospective cohort study of patients electively withdrawn from life sustaining treatment. The investigators and the study have no impact on the decision or timing of withdrawal of support. The study will merely record what and what time support is withdrawn, the medications that are provided for patient comfort, and the time of death. Within this group, we will determine whether patients who "meet" the UNOS criteria (UNOS cohort) have a short time to death, enabling us to validate the current, unvalidated UNOS criteria. In addition, we will analyze data from all patients, perform logistic regression to determine other candidate criteria for determining short time to death. (b) Data extractors will collect the data from all identified patients using chart review following procedures approved by their institutional review board. Data forms will be de-identified at each institution prior to transmission to our central database to ensure patient confidentiality.
The results from the project we are proposing will enable more accurate identification of appropriate candidates for NHBOD. We plan to do this by examining pre-mortem data of patients that have died after withdrawal of LST to see if any factors or combination of factors are predictive of death in less than 30 minutes and 60 minutes after LST is removed.
Our research questions are:
- Do the UNOS criteria predict early death following discontinuation of LST? 2. In addition we will collect data to enable us to address the secondary questions:
- a. What are the best predictors of early death following discontinuation of LST?, and 2.b. How accurate are they?
We intend to test the following two hypotheses:
H1: The UNOS criteria are predictive of death in less than 30 minutes; H2: The UNOS criteria are predictive of death within 60 minutes.
The researchers selected the following outcomes for the study. Outcome 1: death within 30 minutes of removal of life sustaining treatment. Outcome 2: death within 60 minutes of removal of life sustaining treatment. Outcome 3: number of potential organ donors following cardiac death
Study Type
Enrollment
Contacts and Locations
Study Locations
-
-
Ohio
-
Cincinnati, Ohio, United States, 45267
- University of Cincinnati Medical Center
-
Cleveland, Ohio, United States, 44106
- Case Western Reserve University
-
-
Pennsylvania
-
Pittsburgh, Pennsylvania, United States, 15213
- University of Pittsburgh Medical Center
-
Pittsburgh, Pennsylvania, United States, 15213
- Childrens Hospital of Pittsburgh
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- all patients who have life sustaining treatments withdrawn
Exclusion Criteria:
- confirmed brain death
Study Plan
How is the study designed?
Design Details
- Time Perspectives: Prospective
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Study Chair: Michael A DeVita, MD, University of Pittsburgh/University of Pittsburgh Medical Center
- Principal Investigator: Christine Zowistowski, MD, University of Tennesse, Memphis
- Principal Investigator: Maria Brooks, PhD, University of Pittsburgh
Study record dates
Study Major Dates
Study Start
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 0409061
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Withdrawing Treatment
-
Psychiatric Centre RigshospitaletAstraZenecaTerminatedMedical Treatment | Antipsychotic Treatment | Quality AssuranceDenmark
-
Vilniaus Implantologijos Centro (VIC) KlinikaInstitut Straumann AGActive, not recruitingSingle Implant; Immediate Implant Treatment; Early Implant TreatmentLithuania
-
Zagazig UniversityNot yet recruiting
-
Ajman UniversityCompletedTreatmentUnited Arab Emirates
-
Nanjing University School of MedicineCompleted
-
Entheon Biomedical Corp.CompletedTreatment-resistant DepressionUnited States
-
Eunice Kennedy Shriver National Institute of Child...Withdrawn
-
The University of Texas Health Science Center at...Patient-Centered Outcomes Research InstituteCompletedStandard Treatment Versus Engagement Focused TreatmentUnited States
-
All India Institute of Medical Sciences, BhubaneswarRecruitingTreatment Resistant SchizophreniaIndia
-
Suzhou Puhe Pharmaceutical Technology Co., LTDRecruitingTreatment Side Effects | TreatmentChina
Clinical Trials on withdrawal of life sustaining treatments
-
Radboud University Medical CenterCompletedTissue and Organ ProcurementNetherlands
-
University of PennsylvaniaCompleted
-
University Hospital, GrenobleCompletedPost Traumatic Stress DisorderFrance
-
Seoul National University HospitalNational Evidence-Based Healthcare Collaborating Agency; National Clinical... and other collaboratorsCompletedHealthyKorea, Republic of
-
Centre Hospitalier Universitaire de BesanconRecruiting
-
OHSU Knight Cancer InstituteOregon Health and Science University; American Cancer Society, Inc.Recruiting
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingHematopoietic and Lymphoid Cell Neoplasm | Malignant Solid NeoplasmUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingMetastatic Renal Cell Carcinoma | Stage IV Renal Cell Cancer AJCC v8United States
-
Ohio State University Comprehensive Cancer CenterActive, not recruitingAnatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage IA Breast Cancer AJCC v8 | Anatomic Stage IB Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage IIA Breast Cancer AJCC v8 | Anatomic Stage IIB Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Anatomic... and other conditionsUnited States
-
M.D. Anderson Cancer CenterRecruitingHematopoietic and Lymphoid Cell Neoplasm | Malignant Solid NeoplasmUnited States